Tongue Cancer Completed Phase 1 Trials for DB00398 (Sorafenib)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02035527Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTreatment